Characterized as a progressive neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra, Parkinson’s disease is affecting an ever greater number of people around the world as global life expectancy rises. As the disease progresses, it has physical, mental, emotional, social, and economic impacts on the patient, eroding their quality of life. Many studies have been done to understand what leads to the onset of the disease and to develop treatments or even prevention. This study uses technology foresight by identifying patents and scientific articles related to drugs for the treatment of the disease with the purpose of assessing the progress of research over time and map out the countries and companies that control the related technologies.
Full-text available at http://www.ijrpb.org/pdf/v2-i3/4.pdf
Author(s): Karinne Marieta Carvalho , Eduardo Winter , Adelaide Maria de Souza Antunes
Organization(s): Federal University of Rio de Janeiro and National Institute of Industrial Property
Source: International Journal of Research in Pharmacy and Biosciences